Stock MLAB MESA LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Mesa Laboratories, Inc.

Equities

MLAB

US59064R1095

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-16 pm EDT 		5-day change 1st Jan Change
102.5 USD -1.87% Intraday chart for Mesa Laboratories, Inc. -4.11% -2.17%
Apr. 08 Mesa Laboratories, Inc. Amends and Restates Its Senior Secured Credit Agreement with Syndicate of Banks Led by JPMorgan Chase Bank, N.A CI
Apr. 05 Mesa Laboratories, Inc. Declares Regular Quarterly Dividend, Payable on June 14, 2024 CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Mesa Laboratories, Inc.

Mesa Laboratories, Inc. Amends and Restates Its Senior Secured Credit Agreement with Syndicate of Banks Led by JPMorgan Chase Bank, N.A CI
Mesa Laboratories, Inc. Declares Regular Quarterly Dividend, Payable on June 14, 2024 CI
Mesa Laboratories, Inc. announced that it expects to receive $71.25 million in funding CI
Mesa Laboratories, Inc. Provides Impairment Guidance for the Fourth Quarter of 2024 CI
Earnings Flash (MLAB) MESA LABORATORIES Posts Q3 Revenue $53.5M MT
Earnings Flash (MLAB) MESA LABORATORIES Reports Q3 EPS $2.02 MT
Mesa Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Mesa Laboratories, Inc. Appoints Mark Capone to Its Board of Directors CI
Mesa Laboratories Maintains Quarterly Dividend at $0.16 a Share, Payable March 15 to Shareholders of Record as of Feb. 29 MT
Mesa Laboratories, Inc. Declares Regular Quarterly Dividend, Payable on March 15, 2024 CI
Evercore ISI Upgrades Mesa Laboratories to Outperform From In-Line, Raises Price Target to $125 From $100 MT
Mesa Laboratories Completes Acquisition of GKE's Chinese Sales Entity MT
Mesa Laboratories, Inc. acquired Beijing GKE Science & Technology Co. LTD for ?5 million CI
Earnings Flash (MLAB) MESA LABORATORIES Posts Q2 Revenue $53.2M MT
Earnings Flash (MLAB) MESA LABORATORIES Posts Q2 EPS $1.91 MT
Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005. CI
Mesa Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Mesa Laboratories Completes Acquisition of GKE's Sterilization Indicators Business, Testing Lab SAL MT
Mesa Laboratories, Inc. entered into a definitive agreement to acquire Beijing GKE Science & Technology Co. LTD for ?5 million. CI
Mesa Laboratories, Inc. acquired Sterilization indicators business of GKE-GmbH and SAL GmbH from Gke-GmbH for ?80 million. CI
Mesa Laboratories, Inc. Amends Four-Year Senior Secured Credit Agreement CI
Mesa Laboratories Keeps Quarterly Dividend at $0.16 a Share, Payable Dec. 15 to Shareholders of Record as of Nov. 30 MT
Mesa Laboratories, Inc. Declares Quarterly Dividend, Payable on December 15, 2023 CI
Mesa Laboratories Inc Insider Sold Shares Worth $492,890, According to a Recent SEC Filing MT
Mesa Laboratories Insider Sold Shares Worth $369,965, According to a Recent SEC Filing MT

Chart Mesa Laboratories, Inc.

Chart Mesa Laboratories, Inc.
More charts

Company Profile

Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-05-24 - Q4 2024 Earnings Release
Related indices
Russell 2000
More about the company

Income Statement Evolution

More financial data

Ratings for Mesa Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
104.4 USD
Average target price
130 USD
Spread / Average Target
+24.46%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
MESA LABORATORIES, INC. Stock Mesa Laboratories, Inc.
-2.17% 563M
ABBOTT LABORATORIES Stock Abbott Laboratories
-0.78% 189B
MEDTRONIC PLC Stock Medtronic plc
-3.80% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.26% 67.81B
DEXCOM, INC. Stock DexCom, Inc.
+10.02% 51.87B
CENCORA, INC. Stock Cencora, Inc.
+16.01% 46.67B
HOYA CORPORATION Stock Hoya Corporation
-0.77% 38.68B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+7.77% 27.73B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+1.26% 26.6B
SARTORIUS STEDIM BIOTECH Stock Sartorius Stedim Biotech
+5.43% 26.34B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. MLAB Stock
  4. News Mesa Laboratories, Inc.
  5. Insider Sell: Mesa Laboratories